Qualigen (QGEN), formerly Ritter Pharmaceuticals, develops novel therapeutic products that includes gut microbiome modulation for gastrointestinal diseases, treatment for lactose intolerance (RP-G28), and other variety
Stockpence is currently seeking to expand our team of contributors. We’re looking for financial gurus & article writers to write about trending market news and investment ideas about the stock market.
If you’re interested please contact us!
Investing involves substantial risk. Neither the authors, the publisher, nor any of their respective affiliates make any guarantee or other promise as to any results that may be obtained from the articles herein. No reader should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, on any featured company here.
Some of the companies featured here may pay a fee to an affiliate of the publication to broaden awareness of said company.
The principals of the publication may buy or sell shares of the featured companies from time-to-time.
Join our free mailing list below to receive real-time news alerts and our next featured stock!
Investing involves substantial risk. Neither the Authors, the publisher, nor any of their respective affiliates make any guarantee or other promise as to any results that may be obtained from the articles herein. No reader should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, on any featured company here.
Some of the companies featured here may pay a fee to an affiliate of the publication to broaden awareness of said company.
The principals of the publication may buy or sell shares of the featured companies from time-to-time.
Join our free mailing list below to receive real-time news alerts and our next featured stock!
